Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Tests a powered hip device for walking in people with relapsing multiple sclerosis

Tests a powered hip-assist device on walking in adults with relapsing multiple sclerosis.

Plain-language title generated from the registry record
Registry title: Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

Key facts

Where
Dayton, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07724093, who can take part

Where in United States

  • University of DaytonDayton, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Dayton
Trial code
NCT07724093
Record updated
23 July 2026
Original description
The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?Read full original descriptionShow less

The Effects of a Powered Hip Flexion Orthosis on Gait in Persons With Multiple Sclerosis: a Case Series

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?

Inclusion: Age 18-80; Diagnosis of relapsing remitting, primary progressive or secondary progressive MS; Unilateral or bilateral hip flexion weakness (Manual muscle testing score of 3 or less); Ability to walk at least 30 meters without requiring rest and without physical support or assistance from another person; Waist circumference 26-48", Height 5 '- 6'2", Weight 100-230lbs.

Exclusion: Prior regular use of a hip flexion orthosis within the past 6 months; Any other neurological conditions that may affect gait; Cognitive or communication deficits that would limit ability to participate safely; Significant pain or deformity of the lower extremities that could impact walking ability; Severe spasticity (Modified Ashworth Score of 3 or 4) of the hips or lower extremities that could impact walking ability.

ClinicalTrials.gov NCT07724093